lol... holding RXMD Filings and OTC NEWS up to a mirror....is what it is! Promotions of RXMD to Nasdaq or comparing misleading comparisons to CVS ARE THE FALSE statements
NOT Selling a SINGLE share, during a run from under .01 to $.26, and waiting for $2.00... Would have been my biggest failure. Glad it wasn't me!